ARTBIO

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$90M

ARTBIO is a clinical-stage biotech firm specializing in developing alpha radioligand therapies for cancer treatment, currently advancing its proprietary technology and lead prostate cancer program through clinical trials.